CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase 2a, Double-Blind, Randomized, Active Controlled, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Bezafibrate Administered in Combination With Obeticholic Acid in Subjects With Primary Biliary Cholangitis

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05239468
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-07-17T00:09:18.577952+00:00
Published At: 2026-07-16T00:00:00+00:00
Record Updated At: 2026-07-16
Results Posted At: 2026-07-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Primary Biliary Cholangitis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-07-16"
protocolSection.identificationModule.nctId: "NCT05239468"
protocolSection.identificationModule.officialTitle: "A Phase 2a, Double-Blind, Randomized, Active Controlled, Parallel Group Study Evaluating the Efficacy, Safety, and Tolerability of Bezafibrate Administered in Combination With Obeticholic Acid in Subjects With Primary Biliary Cholangitis"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-07-16"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.